Parkinson’s disease (PD) presents varying motor and non-motor features in each patient owing to their different backgrounds, such as age, gender, genetics, and environmental factors. Furthermore, in the advanced stages, troublesome symptoms vary between patients due to motor and non-motor complications. The treatment of PD has made great progress over recent decades and has directly contributed to an improvement in patients’ quality of life, especially through the progression of advanced treatment. Deep brain stimulation, radiofrequency, MR–guided focused ultrasound, gamma knife, levodopa-carbidopa intestinal gel, and apomorphine are now used in the clinical setting for this disease. With multiple treatment options currently available for a...
Understanding the pathophysiology and genetic background of Parkinson’s disease (PD) increases the l...
Parkinson’s disease (PD) is the most common movement disorder and is second behind Alzheimer’s disea...
Device-aided therapies, including levodopa-carbidopa intestinal gel infusion, apomorphine subcutaneo...
Parkinson’s disease (PD) is a chronic, progressive neurological disorder and the second most common ...
Device-aided therapies, including levodopa-carbidopa intestinal gel infusion, apomorphine subcutaneo...
Device-aided therapies, including levodopa-carbidopa intestinal gel infusion, apomorphine subcutaneo...
Device-aided therapies, including levodopa-carbidopa intestinal gel infusion, apomorphine subcutaneo...
Parkinson’s disease (PD) is a progressive neurodegenerative disorder that currently has no cure, but...
Parkinson Disease is an incurable neurological disease which affects the Central Nervous System. It ...
Parkinson's disease (PD) is a common neurodegenerative disease typified by a movement disorder consi...
Device-aided therapies, including levodopa-carbidopa intestinal gel infusion, apomorphine subcutaneo...
Parkinson’s disease (PD) is the second most common neurodegenerative illness that affects the centra...
In recent years, numerous clinical trials for disease modification in Parkinson’s disease (PD) have ...
Parkinson’s disease (PD) is a neurodegenerative disorder pathologically distinguished by degeneratio...
Parkinson’s Disease (PD) is a neurocognitive disease that has an insidious and progressive nature. T...
Understanding the pathophysiology and genetic background of Parkinson’s disease (PD) increases the l...
Parkinson’s disease (PD) is the most common movement disorder and is second behind Alzheimer’s disea...
Device-aided therapies, including levodopa-carbidopa intestinal gel infusion, apomorphine subcutaneo...
Parkinson’s disease (PD) is a chronic, progressive neurological disorder and the second most common ...
Device-aided therapies, including levodopa-carbidopa intestinal gel infusion, apomorphine subcutaneo...
Device-aided therapies, including levodopa-carbidopa intestinal gel infusion, apomorphine subcutaneo...
Device-aided therapies, including levodopa-carbidopa intestinal gel infusion, apomorphine subcutaneo...
Parkinson’s disease (PD) is a progressive neurodegenerative disorder that currently has no cure, but...
Parkinson Disease is an incurable neurological disease which affects the Central Nervous System. It ...
Parkinson's disease (PD) is a common neurodegenerative disease typified by a movement disorder consi...
Device-aided therapies, including levodopa-carbidopa intestinal gel infusion, apomorphine subcutaneo...
Parkinson’s disease (PD) is the second most common neurodegenerative illness that affects the centra...
In recent years, numerous clinical trials for disease modification in Parkinson’s disease (PD) have ...
Parkinson’s disease (PD) is a neurodegenerative disorder pathologically distinguished by degeneratio...
Parkinson’s Disease (PD) is a neurocognitive disease that has an insidious and progressive nature. T...
Understanding the pathophysiology and genetic background of Parkinson’s disease (PD) increases the l...
Parkinson’s disease (PD) is the most common movement disorder and is second behind Alzheimer’s disea...
Device-aided therapies, including levodopa-carbidopa intestinal gel infusion, apomorphine subcutaneo...